Entry
Name
Vipadenant (USAN/INN)
Formula
C16H15N7O
Exact mass
321.1338
Mol weight
321.3366
Structure
Mol file KCF file DB search
Class
Neuropsychiatric agent
DG01967 Antiparkinson agent
Efficacy
Antiparkinsonian, Adenosine A2A receptor antagonist
Comment
Treatment of Parkinson's disease
Target
Pathway
hsa04080 Neuroactive ligand-receptor interaction
Interaction
DDI search
Structure map
Brite
Drug groups [BR:br08330 ]
Neuropsychiatric agent
DG01967 Antiparkinson agent
D09991 Vipadenant
Target-based classification of drugs [BR:br08310 ]
G Protein-coupled receptors
Rhodopsin family
Adenosine
ADORA2A
D09991 Vipadenant (USAN/INN)
BRITE hierarchy
Other DBs
KCF data
Show ATOM 24
1 C8x C 11.6900 -23.5200
2 C8x C 11.6900 -24.9200
3 O2x O 13.0200 -25.3400
4 C8y C 13.8600 -24.2200
5 C8x C 13.0200 -23.1000
6 C8y C 15.2600 -24.2200
7 N5x N 15.9600 -25.4100
8 C8y C 17.3600 -25.4100
9 N5x N 18.0600 -24.2200
10 C8y C 17.3600 -23.0300
11 C8y C 15.9600 -23.0300
12 N4y N 17.7800 -21.7000
13 N5x N 16.6600 -20.8600
14 N5x N 15.5400 -21.7000
15 N1a N 18.0600 -26.6000
16 C1b C 18.9700 -21.0000
17 C8y C 20.1600 -21.7000
18 C8x C 20.1600 -23.1000
19 C8x C 21.4200 -23.8000
20 C8y C 22.6100 -23.1000
21 C8y C 22.6100 -21.7000
22 C8x C 21.4200 -21.0000
23 C1a C 23.8253 -21.0049
24 N1a N 23.8253 -23.7951
BOND 27
1 1 2 2
2 2 3 1
3 3 4 1
4 4 5 2
5 1 5 1
6 4 6 1
7 6 7 2
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 6 11 1
13 10 12 1
14 12 13 1
15 13 14 2
16 11 14 1
17 8 15 1
18 16 17 1
19 16 12 1
20 17 18 1
21 18 19 2
22 19 20 1
23 20 21 2
24 21 22 1
25 17 22 2
26 21 23 1
27 20 24 1